About Tebler
Tebler is a Healthcare company based in India. Pharmaceutical research, product development, and delivery of medications in India. The company has 1 employees. Tebler offers products and services including Raziler D and Acyphylin. Its focus areas include Pharmaceuticals, Drug Manufacturing, Medications and Biotechnology. Its legal entity in India is Tebler Life Sciences Pvt. Ltd (U24230DL2022PTC403872).
Company details
Tebler Life Sciences is identified as a pharmaceutical company that prioritizes research and innovation to produce high-quality products. Cutting-edge technologies and industry standards are utilized to ensure the efficacy and safety of offerings such as Raziler D and Acyphylin, which are designed to enhance global healthcare. A dedicated team is employed to develop novel therapies and medications, with operations based in New Delhi, India. The companys efforts are focused on transforming lives through reliable pharmaceutical solutions.
- Headquarters India
- Employees 1
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Legal Name Tebler Life Sciences Pvt. Ltd
- Date of Incorporation 29 Aug, 2022
- Jurisdiction Delhi, India
- Annual Revenue₹32,754
FY 2023
- Net Loss-₹11,396
FY 2023 · -35% margin
- EBITDA-₹11,396
FY 2023 · -35% margin
- Employee Count1
Associated legal entities of Tebler
Tebler operates through Tebler Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Tebler Life Sciences Private Limited CIN U24230DL2022PTC403872 | Active | 29 Aug 2022 | Delhi, Delhi | ₹0.0 Cr | 3 | View details |
Products & Services of Tebler
Tebler offers a comprehensive portfolio of products and services, including Raziler D and Acyphylin.
Raziler D is offered as a medication that is developed for specific health applications
Acyphylin is provided as another medication aimed at therapeutic uses
Board of directors of Tebler Life Sciences Private Limited (Tebler)
Tebler Life Sciences Private Limited is the primary company behind Tebler. The board of Tebler Life Sciences Private Limited currently have 3 directors; the longest-serving is Naziya Khan, appointed in 2022.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Naziya Khan DIN 09720342 | Director | 29 Aug 2022 | 4 yrs 1 mo | Tebler Life Sciences Private Limited |
| Shariqua Anjum DIN 09720433 | Director | 29 Aug 2022 | 4 yrs 1 mo | Tebler Life Sciences Private Limited |
| Nahid Pathan DIN 09720341 | Director | 29 Aug 2022 | 4 yrs 1 mo | Tebler Life Sciences Private Limited |
Financials of Tebler
Figures of Tebler Life Sciences Private Limited, the primary company behind Tebler, for FY 2023. Revenue was ₹32,754. Net loss was -₹11,396 (-35% margin). EBITDA was -₹11,396 (-35% margin).
- ₹32,754Revenue · FY 2023
- -₹11,396Net loss · -35% margin
- -₹11,396EBITDA · -35% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Tebler Life Sciences Private Limited are on its company page.
Detailed financial statements for Tebler
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Tebler
Tebler is headquartered in India.
Tebler has 1 employees.
The primary company behind Tebler, Tebler Life Sciences Private Limited, reported revenue of ₹32,754 for FY 2023.
Tebler Life Sciences is identified as a pharmaceutical company that prioritizes research and innovation to produce high-quality products. Cutting-edge technologies and industry standards are utilized to ensure the efficacy and safety of offerings such as Raziler D and Acyphylin, which are designed to enhance global healthcare. A dedicated team is employed to develop novel therapies and medications, with operations based in New Delhi, India. The companys efforts are focused on transforming lives through reliable pharmaceutical solutions.
Tebler offers Raziler D and Acyphylin.
Tebler operates through Tebler Life Sciences Private Limited.
The legal entities of Tebler currently have 3 directors, including Naziya Khan, Shariqua Anjum, Nahid Pathan.